A cell-to-patient machine learning transfer approach uncovers novel basal-like breast cancer prognostic markers amongst alternative splice variants
J.-P. Villemin, C. Lorenzi, A. Oldfield, M.-S. Cabrillac, W. J. Ritchie, R. F. Luco
This paper uses a machine learning approach to transfer knowledge from breast cancer cell lines to patient data, identifying a splicing signature that subclasses basal-like breast cancers and predicts poor prognosis.
bioRxiv · Nov 12, 2020Cancer Biology